Cargando…

Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

Detalles Bibliográficos
Autores principales: Vanni, Kathleen MM, Patel, Naomi J, DiIorio, Michael, Kowalski, Emily, Qian, Grace, Cook, Claire E, Ritter, Susan Y, Wallace, Zachary S, Sparks, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811273/
https://www.ncbi.nlm.nih.gov/pubmed/35110366
http://dx.doi.org/10.1136/rmdopen-2021-002082
_version_ 1784644394946658304
author Vanni, Kathleen MM
Patel, Naomi J
DiIorio, Michael
Kowalski, Emily
Qian, Grace
Cook, Claire E
Ritter, Susan Y
Wallace, Zachary S
Sparks, Jeffrey A
author_facet Vanni, Kathleen MM
Patel, Naomi J
DiIorio, Michael
Kowalski, Emily
Qian, Grace
Cook, Claire E
Ritter, Susan Y
Wallace, Zachary S
Sparks, Jeffrey A
author_sort Vanni, Kathleen MM
collection PubMed
description
format Online
Article
Text
id pubmed-8811273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88112732022-02-03 Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy Vanni, Kathleen MM Patel, Naomi J DiIorio, Michael Kowalski, Emily Qian, Grace Cook, Claire E Ritter, Susan Y Wallace, Zachary S Sparks, Jeffrey A RMD Open Infections BMJ Publishing Group 2022-02-02 /pmc/articles/PMC8811273/ /pubmed/35110366 http://dx.doi.org/10.1136/rmdopen-2021-002082 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infections
Vanni, Kathleen MM
Patel, Naomi J
DiIorio, Michael
Kowalski, Emily
Qian, Grace
Cook, Claire E
Ritter, Susan Y
Wallace, Zachary S
Sparks, Jeffrey A
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
title Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
title_full Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
title_fullStr Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
title_full_unstemmed Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
title_short Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
title_sort breakthrough infection after three doses of covid-19 mrna vaccine in systemic autoimmune rheumatic diseases: two cases in patients on tnf inhibitor monotherapy
topic Infections
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811273/
https://www.ncbi.nlm.nih.gov/pubmed/35110366
http://dx.doi.org/10.1136/rmdopen-2021-002082
work_keys_str_mv AT vannikathleenmm breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT patelnaomij breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT diioriomichael breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT kowalskiemily breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT qiangrace breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT cookclairee breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT rittersusany breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT wallacezacharys breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy
AT sparksjeffreya breakthroughinfectionafterthreedosesofcovid19mrnavaccineinsystemicautoimmunerheumaticdiseasestwocasesinpatientsontnfinhibitormonotherapy